The Medical Devices Group on LinkedIn is one of the most active groups on the site, and as a member, I often check out what’s being discussed there.
The 100,000-strong group’s owner Joe Hage has in the past flexed his muscle to gain support for repealing the 2.3 percent medical device tax using the forum. It elicited some strong negative reaction with some saying the group was not a place for political activism.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
But a few days ago, a wholly relevant question was posted to the group.
Steven McCluskey, medical device and aerospace manager at emsPT, from Glasgow, U.K. asked: “What is the biggest challenge facing medical device manufacturers today?
In his poll, he provided five choices:
- Reducing the cost of compliance
- Bringing new devices to market quicker
- Improving customer supply and satisfaction
- Reducing overall cost of goods
- Other
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Not surprisingly, a majority of poll respondents (112, including me, so far) selected the second option, while an equal number (23) of people chose either “reducing the overall cost of goods” and “reducing the cost of compliance” as the toughest challenge for medical device makers.
Yet, there were some thoughtful responses from those who likely chose the “other” option.
Talisman Murphy, managing director, Brückenkopf GmbH in Germany, pointed to the problem posed by different regulatory rules in different markets.
Yuri Sokolov, president at Falcon Business Development in Canada, took a more macro approach in talking about the “challenging economic times, budget cuts and austerity measures, reimbursement cuts, and lower discretionary customer incomes.”
And Michael Cremeans, life sciences practice leader from the Cleveland, Ohio area, pointed to the challenge posed by the ability to manage information: “Think about how many departments in a company are affected by, or need information from, an incident — legal, regulatory, financial, quality, risk management, sales, training, design, production AND THEN THERE’S THE FDA REPORTING!”
To read more, consider joining the group.
